drug
fosphenytoin sodium
Marketedupdated 5mo agoby Wockhardt USA LLC
Approvedcommunity read0 votes
indications
investigational
Epilepsy
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 13, 2029
~2.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (10)
- Feb 27, 2033formulationUS 9493582
- Feb 27, 2033formulationUS 9493582
- Mar 13, 2029formulationUS 76357732.4y
- Mar 13, 2029formulationUS 76357732.4y
- Mar 13, 2029formulationUS 84100772.4y
- Mar 13, 2029formulationUS 84100772.4y
- Mar 13, 2029formulationUS 92000882.4y
- Mar 13, 2029formulationUS 92000882.4y
- Mar 13, 2029formulationUS 97508222.4y
- Mar 13, 2029formulationUS 97508222.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that